Back to search results

The NODE-202 Study (Study of Etripamil Nasal Spray in Pediatric Patients)

Abroad (travel likely)RecruitingPHASE2

Conditions

Paroxysmal Supraventricular Tachycardia

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

  • Phoenix Children's Hospital, Phoenix, Arizona, United States

    Contact: Study coordinator (Andrew Papez) · apapez@phoenixchildrens.com
    Contact: Principal Investigator (Andrew Papez)

  • Advocate Children's Hospital, Oak Lawn, Illinois, United States

    Contact: Study coordinator (Frank Zimmerman) · Frank.Zimmerman@aah.org
    Contact: Principal Investigator (Frank Zimmerman)

  • Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, United States

    Contact: Study coordinator (Shankar Baskar) · shankar.baskar@cchmc.org
    Contact: Principal Investigator (Shankar Baskar)

  • Oregon Health and Science University, Portland, Oregon, United States

    Contact: Study coordinator (Seshadri Balaji) · balajis@ohsu.edu
    Contact: Principal Investigator (Seshadri Balaji)

  • Le Bonheur Children's Hospital, Memphis, Tennessee, United States

    Contact: Study coordinator (Karine Guerrier) · kguerrie@uthsc.edu
    Contact: Principal Investigator (Karine Guerrier)

  • Baylor College of Medicine, Houston, Texas, United States

    Contact: Study coordinator (Santiago Valdes) · sovaldes@texaschildrens.org
    Contact: Principal Investigator (Santiago Valdes)

  • The University of British Columbia, Vancouver, Canada

    Contact: Study coordinator (Shubhayan Sanatani)
    Contact: Principal Investigator (Shubhayan Sanatani)

  • Universitätsmedizin Göttingen, Klinik für Pädiatrische Kardiologie, Intensivmedizin und Neonatologie, Göttingen, Germany

    Contact: Study coordinator (Thomas Paul)
    Contact: Principal Investigator (Thomas Paul)

  • Hospital Sant Joan de Déu, Barcelona, Spain

    Contact: Study coordinator (Georgia Brugada)
    Contact: Principal Investigator (Georgia Brugada)

  • Hospital Infantil Universitario La Paz, Madrid, Spain

    Contact: Study coordinator (Jose Merino)
    Contact: Principal Investigator (Jose Merino)
Study leads

  • David Bharucha, MD

    Study Director

    Milestone Pharmaceuticals

View source on ClinicalTrials.gov(opens in a new tab)